相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice
Gi-Su Oh et al.
KIDNEY INTERNATIONAL (2014)
Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity
Gil-Tae Gang et al.
TOXICOLOGY LETTERS (2013)
The ways and means that fine tune Sirt1 activity
Javier R. Revollo et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells
Yu Jin Jung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis
Xiumei Huang et al.
CANCER RESEARCH (2012)
Sirtuins and Pyridine Nucleotides
Maha Abdellatif
CIRCULATION RESEARCH (2012)
Regulation of Cell Survival and Death by Pyridine Nucleotides
Shin-ichi Oka et al.
CIRCULATION RESEARCH (2012)
The Antioxidant 3H-1,2-Dithiole-3-Thione Potentiates Advanced Glycation End-Product-Induced Oxidative Stress in SH-SY5Y Cells
Robert Pazdro et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase
Yong-Hoon Kim et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
A Mutually Inhibitory Feedback Loop between the 20S Proteasome and Its Regulator, NQO1
Oren Moscovitz et al.
MOLECULAR CELL (2012)
Beta-Lapachone, a Modulator of NAD Metabolism, Prevents Health Declines in Aged Mice
Jeong-sook Lee et al.
PLOS ONE (2012)
Drug-Induced Oxidative Stress and Toxicity
Damian G. Deavall et al.
JOURNAL OF TOXICOLOGY (2012)
Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity
Yong-Hoon Kim et al.
CARDIOVASCULAR RESEARCH (2011)
Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy
Long Shan Li et al.
CLINICAL CANCER RESEARCH (2011)
Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels
Roman H. Haefeli et al.
PLOS ONE (2011)
The impact of acetylation and deacetylation on the p53 pathway
Christopher L. Brooks et al.
PROTEIN & CELL (2011)
SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53
Duk Hoon Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Kidney-specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function
Kazuhiro Hasegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity
Hyung-Jin Kim et al.
JOURNAL OF NEUROSCIENCE (2010)
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Raga Krishnakumar et al.
MOLECULAR CELL (2010)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Activation of NAD(P) H:Quinone Oxidoreductase 1 Prevents Arterial Restenosis by Suppressing Vascular Smooth Muscle Cell Proliferation
Sun-Yee Kim et al.
CIRCULATION RESEARCH (2009)
Pharmacological Stimulation of NADH Oxidation Ameliorates Obesity and Related Phenotypes in Mice
Jung Hwan Hwang et al.
DIABETES (2009)
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes
Shin-ichiro Imai et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Parthanatos, a messenger of death
Karen Kate David et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Bruce A. Molitoris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes
Takeshi Yoshizaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt
Marcella Fulco et al.
DEVELOPMENTAL CELL (2008)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cisplatin cytotoxicity of Auditory cells requires secretions of proinflammatory Cytokines via activation of ERK and NF-κB
Hongseob So et al.
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY (2007)
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis
Dohoon Kim et al.
EMBO JOURNAL (2007)
Sirtuins in mammals: insights into their biological function
Shaday Michan et al.
BIOCHEMICAL JOURNAL (2007)
Regulation of antioxidants and phase 2 enzymes by shear-induced reactive oxygen species in endothelial cells
Charles I. Jones et al.
ANNALS OF BIOMEDICAL ENGINEERING (2007)
NAD+ metabolism in health and disease
Peter Belenky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Beyond I kappa Bs: alternative regulation of NF-kappa B activity
Manfred Neumann et al.
FASEB JOURNAL (2007)
Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2α deacetylase activity
JB Pillai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development
KRG Knight et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Mammalian SIRT1 represses forkhead transcription factors
MC Motta et al.
CELL (2004)
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
M Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
F Yeung et al.
EMBO JOURNAL (2004)
Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells
Y Shino et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation
LF Chen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients
FE de Jongh et al.
BRITISH JOURNAL OF CANCER (2003)
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
L Virág et al.
PHARMACOLOGICAL REVIEWS (2002)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissues
A Gaikwad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
NAD(P)H:quinone oxidoreductase 1 (NQO1):: chemoprotection, bioactivation, gene regulation and genetic polymorphisms
D Ross et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
分享论文
